XTL Biopharmaceuticals Ltd. (XTLB.TA)
ILA 4.8
(4.35%)
ILA 4.8
(4.35%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.42 Million USD | -42.04% |
| 2022 | 4.18 Million USD | -36.75% |
| 2021 | 6.61 Million USD | 1.77% |
| 2020 | 6.5 Million USD | -9.83% |
| 2019 | 7.21 Million USD | -15.9% |
| 2018 | 8.57 Million USD | 30.2% |
| 2017 | 6.58 Million USD | 118.3% |
| 2016 | 3.01 Million USD | -43.32% |
| 2015 | 5.32 Million USD | -5.69% |
| 2014 | 5.64 Million USD | -29.58% |
| 2013 | 8.01 Million USD | -27.7% |
| 2012 | 11.08 Million USD | 166.55% |
| 2011 | 4.15 Million USD | 9.53% |
| 2010 | 3.79 Million USD | 431.05% |
| 2009 | 715 Thousand USD | -79.15% |
| 2008 | 3.43 Million USD | -75.72% |
| 2007 | 14.12 Million USD | -47.48% |
| 2006 | 26.9 Million USD | 77.55% |
| 2005 | 15.15 Million USD | -40.87% |
| 2004 | 25.62 Million USD | 3.1% |
| 2003 | 24.85 Million USD | -35.32% |
| 2002 | 38.42 Million USD | -30.27% |
| 2001 | 55.1 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.92 Million USD | 20.69% |
| 2023 Q1 | 3.32 Million USD | -20.64% |
| 2023 FY | 2.42 Million USD | -42.04% |
| 2023 Q4 | 2.42 Million USD | -8.9% |
| 2023 Q3 | 2.66 Million USD | -7.57% |
| 2023 Q2 | 2.88 Million USD | -13.28% |
| 2022 Q2 | 5.75 Million USD | -13.05% |
| 2022 FY | 4.18 Million USD | -36.75% |
| 2022 Q1 | 6.62 Million USD | 0.05% |
| 2022 Q4 | 4.18 Million USD | -14.52% |
| 2022 Q3 | 4.89 Million USD | -14.94% |
| 2021 Q3 | 6.85 Million USD | -1.41% |
| 2021 FY | 6.61 Million USD | 1.77% |
| 2021 Q1 | 7.31 Million USD | 12.43% |
| 2021 Q2 | 6.95 Million USD | -4.9% |
| 2021 Q4 | 6.61 Million USD | -3.46% |
| 2020 Q1 | 7.26 Million USD | 0.79% |
| 2020 Q3 | 6.21 Million USD | -8.53% |
| 2020 Q4 | 6.5 Million USD | 4.72% |
| 2020 FY | 6.5 Million USD | -9.83% |
| 2020 Q2 | 6.78 Million USD | -6.6% |
| 2019 Q1 | 12.43 Million USD | 45.0% |
| 2019 Q3 | 8.28 Million USD | -13.19% |
| 2019 Q2 | 9.54 Million USD | -23.21% |
| 2019 FY | 7.21 Million USD | -15.9% |
| 2019 Q4 | 7.21 Million USD | -12.99% |
| 2018 Q1 | 6.42 Million USD | -2.38% |
| 2018 Q3 | 7.46 Million USD | 16.05% |
| 2018 Q4 | 8.57 Million USD | 14.81% |
| 2018 FY | 8.57 Million USD | 30.2% |
| 2018 Q2 | 6.43 Million USD | 0.11% |
| 2017 Q3 | 6.82 Million USD | -4.84% |
| 2017 Q1 | 7.79 Million USD | 158.4% |
| 2017 FY | 6.58 Million USD | 118.3% |
| 2017 Q4 | 6.58 Million USD | -3.5% |
| 2017 Q2 | 7.17 Million USD | -8.0% |
| 2016 Q1 | 4.75 Million USD | -10.61% |
| 2016 FY | 3.01 Million USD | -43.32% |
| 2016 Q4 | 3.01 Million USD | -25.62% |
| 2016 Q3 | 4.05 Million USD | -6.48% |
| 2016 Q2 | 4.33 Million USD | -8.85% |
| 2015 FY | 5.32 Million USD | -5.69% |
| 2015 Q4 | 5.32 Million USD | -28.88% |
| 2015 Q3 | 7.48 Million USD | -4.78% |
| 2015 Q2 | 7.86 Million USD | 56.81% |
| 2015 Q1 | 5.01 Million USD | -11.18% |
| 2014 Q1 | 7.74 Million USD | -3.39% |
| 2014 FY | 5.64 Million USD | -29.58% |
| 2014 Q2 | 7.22 Million USD | -6.7% |
| 2014 Q3 | 6.68 Million USD | -7.42% |
| 2014 Q4 | 5.64 Million USD | -15.61% |
| 2013 Q1 | 10.42 Million USD | -43.48% |
| 2013 FY | 8.01 Million USD | -27.7% |
| 2013 Q4 | 8.01 Million USD | -22.05% |
| 2013 Q3 | 10.28 Million USD | 9.62% |
| 2013 Q2 | 9.38 Million USD | -9.99% |
| 2012 Q1 | 7.86 Million USD | 93.05% |
| 2012 Q4 | 18.43 Million USD | 134.68% |
| 2012 Q2 | 7.33 Million USD | -6.68% |
| 2012 FY | 11.08 Million USD | 166.55% |
| 2012 Q3 | 7.85 Million USD | 7.07% |
| 2011 Q3 | 4.36 Million USD | -7.85% |
| 2011 Q4 | 4.07 Million USD | -6.67% |
| 2011 FY | 4.15 Million USD | 9.53% |
| 2011 Q2 | 4.73 Million USD | -7.55% |
| 2011 Q1 | 5.12 Million USD | 34.92% |
| 2010 Q3 | 3.99 Million USD | 919.13% |
| 2010 FY | 3.79 Million USD | 431.05% |
| 2010 Q4 | 3.79 Million USD | -4.96% |
| 2010 Q2 | 392 Thousand USD | -23.29% |
| 2010 Q1 | 511 Thousand USD | -28.53% |
| 2009 Q4 | 715 Thousand USD | -18.1% |
| 2009 FY | 715 Thousand USD | -79.15% |
| 2009 Q3 | 873 Thousand USD | 0.0% |
| 2008 FY | 3.43 Million USD | -75.72% |
| 2008 Q4 | 3.43 Million USD | 0.0% |
| 2008 Q2 | 9.38 Million USD | 0.0% |
| 2007 Q4 | 14.12 Million USD | 0.0% |
| 2007 Q2 | 13.56 Million USD | 0.0% |
| 2007 FY | 14.12 Million USD | -47.48% |
| 2006 Q2 | 33.8 Million USD | 0.0% |
| 2006 FY | 26.9 Million USD | 77.55% |
| 2006 Q4 | 26.9 Million USD | 0.0% |
| 2005 Q4 | 15.15 Million USD | 0.0% |
| 2005 Q2 | 19.97 Million USD | 0.0% |
| 2005 FY | 15.15 Million USD | -40.87% |
| 2004 FY | 25.62 Million USD | 3.1% |
| 2004 Q4 | 25.62 Million USD | 0.0% |
| 2004 Q2 | 16.28 Million USD | 0.0% |
| 2003 FY | 24.85 Million USD | -35.32% |
| 2002 FY | 38.42 Million USD | -30.27% |
| 2001 FY | 55.1 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Matricelf Ltd | 39.49 Million ILA | 93.857% |